Drug · DIN 02571366
CLOPIDOGREL
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since September 10, 2026.
- Drug Identification Number (DIN)
- 02571366
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Clopidogrel B01AC04
- Class
- Human
- Record last updated
- September 15, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CLOPIDOGREL (CLOPIDOGREL BISULFATE) | 300 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 10, 2026: NOC 38273Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement between two manufacturers
Other DINs named CLOPIDOGREL
- DIN 02385813 · Marketed
- DIN 02394820 · Marketed
- DIN 02400553 · Marketed